150 related articles for article (PubMed ID: 24431292)
1. A single institution experience with the new bethesda system for reporting thyroid cytopathology: correlation with existing cytologic, clinical, and histological data.
McElroy MK; Mahooti S; Hasteh F
Diagn Cytopathol; 2014 Jul; 42(7):564-9. PubMed ID: 24431292
[TBL] [Abstract][Full Text] [Related]
2. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
3. A simplified Bethesda System for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks.
Walts AE; Bose S; Fan X; Frishberg D; Scharre K; de Peralta-Venturina M; Zhai J; Marchevsky AM
Diagn Cytopathol; 2012 May; 40 Suppl 1():E62-8. PubMed ID: 21557534
[TBL] [Abstract][Full Text] [Related]
4. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.
Theoharis CG; Schofield KM; Hammers L; Udelsman R; Chhieng DC
Thyroid; 2009 Nov; 19(11):1215-23. PubMed ID: 19888859
[TBL] [Abstract][Full Text] [Related]
5. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
[TBL] [Abstract][Full Text] [Related]
6. Follicular lesion of undetermined significance in thyroid FNA revisited.
Walts AE; Mirocha J; Bose S
Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
[TBL] [Abstract][Full Text] [Related]
7. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
9. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
10. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens.
Olson MT; Boonyaarunnate T; Aragon Han P; Umbricht CB; Ali SZ; Zeiger MA
J Clin Endocrinol Metab; 2013 Apr; 98(4):1450-7. PubMed ID: 23436916
[TBL] [Abstract][Full Text] [Related]
11. The impact of implementing The Bethesda System for reporting of thyroid FNA at an academic center.
Theoharis C; Adeniran AJ; Roman S; Sosa JA; Chhieng D
Diagn Cytopathol; 2013 Oct; 41(10):858-63. PubMed ID: 23512999
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
13. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
Arnold MA; Nicol KK
Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
[TBL] [Abstract][Full Text] [Related]
14. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?
VanderLaan PA; Marqusee E; Krane JF
Am J Clin Pathol; 2011 May; 135(5):770-5. PubMed ID: 21502433
[TBL] [Abstract][Full Text] [Related]
16. Experience with standardized thyroid fine-needle aspiration reporting categories: follow-up data from 529 cases with "indeterminate" or "atypical" reports.
Nga ME; Kumarasinghe MP; Tie B; Sterrett GF; Wood B; Walsh J; Nguyen H; Whyte A; Frost FA
Cancer Cytopathol; 2010 Dec; 118(6):423-33. PubMed ID: 20945329
[TBL] [Abstract][Full Text] [Related]
17. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.
Crowe A; Linder A; Hameed O; Salih C; Roberson J; Gidley J; Eltoum IA
Cancer Cytopathol; 2011 Oct; 119(5):315-21. PubMed ID: 21751427
[TBL] [Abstract][Full Text] [Related]
18. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Jo VY; Stelow EB; Dustin SM; Hanley KZ
Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
[TBL] [Abstract][Full Text] [Related]
19. Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy?
Srbova L; Gabalec F; Ryska A; Cap J
Cytopathology; 2015 Aug; 26(4):231-7. PubMed ID: 25077794
[TBL] [Abstract][Full Text] [Related]
20. The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology.
Krane JF; Vanderlaan PA; Faquin WC; Renshaw AA
Cancer Cytopathol; 2012 Apr; 120(2):111-6. PubMed ID: 21919213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
